European equities traded in the US as American depositary receipts were treading water late Wednesday morning, edging 0.03% lower to 1,397.50 on the S&P Europe Select ADR Index. From continental ...

Appellate courts issued a variety of notable intellectual property (IP) cases in 2024, including cases touching on Orange Book ...

US President Donald Trump has announced plans to introduce new 25% tariffs on all steel and aluminium imports.

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

Amarin v Hikma. Partner Charles Klein represents Hikma Pharmaceuticals in its dispute with Amarin Pharmaceuticals over Hikma’s generic version of blockbuster heart drug Vascepa. In June 2024, Amarin ...

LONDON, Jan 21 (Reuters) - President Donald Trump is pulling the U.S. out of the World Health Organization, raising concerns about the U.N. agency's ability to fight diseases and respond to ...

Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...

Operating within Purdue’s William D. and Sherry L. Young Institute for Advanced Manufacturing of Pharmaceuticals, consortium partners will revolutionize pharmaceutical manufacturing with a focus on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...